Bellevue Asset Management (Switzerland)’s Impax Laboratories, Inc. IPXL Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$770K	Hold	18,000	–	–	0.12%	110
2015 Q3	$634K	Sell	18,000 -14,600	-45%	-$658K	0.1%	116
2015 Q2	$1.5M	Hold	32,600	–	–	0.21%	101
2015 Q1	$1.53M	Buy	+32,600	New	+$1.3M	0.21%	104

Other funds holding IPXL

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s IPXL Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) held its Impax Laboratories, Inc. (IPXL) position steady in Q4 2015 at 18,000 shares worth $770K. The position accounts for 0.12% of the portfolio, ranked #110.

Bellevue Asset Management (Switzerland) first reported a position in IPXL in Q1 2015 and has held it in 4 quarters since. The position peaked at $1.53M in Q1 2015. 196 funds tracked by Wall St. Rank hold IPXL as of Q4 2015.

Bellevue Asset Management (Switzerland) held 18,000 shares of Impax Laboratories, Inc. worth $770K as of Q4 2015.
Bellevue Asset Management (Switzerland) left its Impax Laboratories, Inc. share count unchanged in Q4 2015.
Impax Laboratories, Inc. made up 0.12% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #110 holding.
Bellevue Asset Management (Switzerland) first reported a position in Impax Laboratories, Inc. in Q1 2015 and has held it in 4 quarters since.
Bellevue Asset Management (Switzerland)'s Impax Laboratories, Inc. position peaked at $1.53M in Q1 2015.
196 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.